New Orleans

New Orleans, Louisiana 70127

1 studies enrolling now · 8 studies all time

What they study most

C. Diff, C. Difficile, CDI, Clostridium Difficile Infection, Clostridium Difficile Infection (CDI), Clostridium Difficile Infection Recurrence, Communicable Diseases, Contraception, Endometriosis, Endometriosis Related Pain, FMT, Fecal Microbiota

Studies at this site

• A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uterine Fibroids or Endometriosis — Recruiting now
• Study of the Safety and Contraceptive Efficacy of Relugolix Combination Therapy in Women With Uterine Fibroids or Endometriosis Who Are at Risk for Pregnancy — Completed
• Microbiota Restoration Therapy for Recurrent Clostridium Difficile Infection (PUNCH CD3-OLS) — Completed
• Microbiota Restoration Therapy for Recurrent Clostridium Difficile Infection (PUNCHCD3) — Completed
• Efficacy, Safety, and Tolerability Study of Oral Full-Spectrum MicrobiotaTM (CP101) in Subjects With Recurrent C. Diff — Completed
• Open-Label Extension of CP101 Trials Evaluating Oral Full-Spectrum Microbiota™ (CP101) in Subjects With Recurrence of Clostridium Difficile Infection — Completed
• LIBERTY 2: Efficacy & Safety Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids — Completed
• SPIRIT 1: Efficacy and Safety Study of Relugolix in Women With Endometriosis-Associated Pain — Completed